top of page
Pure Point Labs Logo.png

Tizepatide

$89.00Price
Quantity

Tirzepatide is being researched for its effects on glucose-dependent insulin secretion, glucagon suppression, gastric emptying, and appetite regulation.

 

Primary areas of study include glycemic control in type 2 diabetes models and body weight management in obesity research.

 

It was developed by Eli Lilly and Company (LY3298176), with initial patent filings and research beginning in 2016.

  • Every product Pure Bio Science offers undergoes thorough independent testing at top-tier U.S. laboratories, guaranteeing that our peptides deliver consistent, exceptional quality you can trust."

    View Third Party Lab Test Results 

bottom of page